anmelden
GSK Aktie
22,08
EUR
-0,42
EUR
-1,87
%
18,96
GBP
-0,32
GBP
-1,63
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 90,39 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.10.24 | GSK Neutral | UBS AG | |
| 11.10.24 | GSK Buy | Deutsche Bank AG | |
| 11.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.10.24 | GSK Buy | Deutsche Bank AG | |
| 10.10.24 | GSK Neutral | UBS AG | |
| 10.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 09.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.10.24 | GSK Buy | Deutsche Bank AG | |
| 09.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 08.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 03.10.24 | GSK Buy | Jefferies & Company Inc. | |
| 03.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.09.24 | GSK Buy | Jefferies & Company Inc. | |
| 17.09.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 16.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 11.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 09.09.24 | GSK Buy | Deutsche Bank AG | |
| 16.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 15.08.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 02.08.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.08.24 | GSK Halten | DZ BANK | |
| 01.08.24 | GSK Buy | Deutsche Bank AG | |
| 01.08.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.08.24 | GSK Neutral | UBS AG | |
| 31.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 31.07.24 | GSK Buy | Deutsche Bank AG | |
| 31.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 10.07.24 | GSK Buy | Deutsche Bank AG | |
| 08.07.24 | GSK Neutral | UBS AG | |
| 04.07.24 | GSK Buy | Deutsche Bank AG | |
| 04.07.24 | GSK Buy | UBS AG | |
| 02.07.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.07.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.06.24 | GSK Buy | UBS AG | |
| 19.06.24 | GSK Buy | Deutsche Bank AG | |
| 18.06.24 | GSK Buy | UBS AG | |
| 18.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.06.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 17.06.24 | GSK Buy | Jefferies & Company Inc. | |
Werbung
Werbung
